Antibiotic treatment of ceftriaxone-susceptible Serratia marcescens bacteremia: A multicenter, retrospective cohort study
Our study found that cefepime- or carbapenem-based therapy may have limited clinical relevance in the treatment of <i>Serratia</i> bacteremia when the strains are initially susceptible to ceftriaxone, highlighting the importance of antibiotic stewardship to prevent emergence of multidrug resistant organisms.
Authors
- Claudia Nader
- Aislinn Brooks
- Julian Maamari (ORCID: https://orcid.org/0000-0002-6813-2179)
- Abdallah Mughrabi (ORCID: https://orcid.org/0000-0001-9225-278X)
- Bertrand L. Jaber (ORCID: https://orcid.org/0000-0003-0577-0605)
- Rinat Nuriev (ORCID: https://orcid.org/0000-0002-0134-2630)
- Lisa Zenkin
- Timothy D. Phillips
- Afaq Alabbasi
Publication Details
- Journal
- International Journal of Clinical Pharmacology and Therapeutics
- Published
- 2024-12-31
- DOI
- https://doi.org/10.5414/cp204652
- Citations
- 1
- Primary Topic
- Antibiotics Pharmacokinetics and Efficacy
- Type
- article
- Field-Weighted Citation Impact
- 0.45